Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2016-10-18 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HARFLEUR (76700), Seine-Maritime
PHARMACIE LEMAISTRE : revenue, balance sheet and financial ratios
PHARMACIE LEMAISTRE is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HARFLEUR (76700),
this company of category PME
shows in 2022 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LEMAISTRE (SIREN 823197173)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
2 902 691 €
N/C
2 518 897 €
N/C
N/C
N/C
Net income
228 109 €
264 115 €
317 047 €
306 372 €
251 037 €
228 137 €
226 687 €
66 258 €
EBITDA
N/C
N/C
439 889 €
N/C
372 379 €
N/C
N/C
N/C
Net margin
N/C
N/C
10.9%
N/C
10.0%
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE LEMAISTRE generates positive net income of 228 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 66 k€ -> 228 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
228 109 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1686%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 5%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1686.005%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
4.987%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
670.094
351.069
240.927
206.097
144.685
102.823
83.066
1686.005
Financial autonomy
11.453
19.498
26.768
29.999
36.703
44.451
48.056
4.987
Repayment capacity
None
None
None
5.055
None
3.24
None
None
Cash flow / Revenue
None%
None%
None%
10.681%
None%
11.401%
None%
None%
Sector positioning
Debt ratio
1686.012024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average+18 pts over 3 years
In 2024, the debt ratio of PHARMACIE LEMAISTRE (1686.01) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
4.99%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch-24 pts over 3 years
In 2024, the financial autonomy of PHARMACIE LEMAISTRE (5.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
3.24 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE LEMAISTRE (3.24) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 194.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
166.515
182.903
219.753
213.29
215.204
243.971
213.194
194.062
Interest coverage
None
None
None
3.367
None
2.307
None
None
Sector positioning
Liquidity ratio
194.062024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good-11 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE LEMAISTRE (194.06) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.31x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE LEMAISTRE (2.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE LEMAISTRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
115 114 €
0 €
150 243 €
0 €
0 €
Inventory turnover (days)
0
0
0
19
0
21
0
0
Customer payment term (days)
0
0
0
2
0
1
0
0
Supplier payment term (days)
0
0
0
26
0
31
0
0
Positioning of PHARMACIE LEMAISTRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE LEMAISTRE is estimated at
3 184 570 €
(range 2 217 684€ - 4 764 299€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2217k€3184k€4764k€
3 184 570 €Range: 2 217 684€ - 4 764 299€
NAF 5 année 2024
Valuation method used
Net Income Multiple
228 109 €
×
14.0x
=3 184 570 €
Range: 2 217 684€ - 4 764 299€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LEMAISTRE with other companies in the same sector:
Frequently asked questions about PHARMACIE LEMAISTRE
What is the revenue of PHARMACIE LEMAISTRE ?
The revenue of PHARMACIE LEMAISTRE in 2022 is 2.9 M€.
Is PHARMACIE LEMAISTRE profitable?
Yes, PHARMACIE LEMAISTRE generated a net profit of 228 k€ in 2024.
Where is the headquarters of PHARMACIE LEMAISTRE ?
The headquarters of PHARMACIE LEMAISTRE is located in HARFLEUR (76700), in the department Seine-Maritime.
Where to find the tax return of PHARMACIE LEMAISTRE ?
The tax return of PHARMACIE LEMAISTRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LEMAISTRE operate?
PHARMACIE LEMAISTRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart